Matthias Guckenberger: First esophageal cancer patient enrolled into randomized protect trial.

Matthias Guckenberger, the Chairman and a Professor of the Department of Radiation Oncology at the University Hospital Zurich, wrote in a recent post: 

”First oesophageal cancer patient enrolled into randomized protect trial, comparing neoadjuvant Photon or Proton radiochemotherapy. Strong collaboration between The Paul Scherrer Institute and The Radiooncology Department of the University Hospital Zurich, Comprehensive Cancer Center Zurich.”